Importantly, low dose treatment with SI-2 of tumor bearing immunodeficient mice failed to suppress tumor growth, which underscores the importance of an intact host immune system toward the totality of the anti-tumor activity that is associated with SRC-3 inhibition. Here, NCOA3 is linked to neoplasm.